REMUS — Remus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹8.21bn
- IN₹8.29bn
- IN₹8.54bn
Brief: Remus Pharmaceuticals Incorporates Subsidiary For Clinical Trial Material Management
Brief: Remus Pharmaceuticals Acquiring Membership Interest Of 56.67% In Espee Global Holdings
Brief: Remus Pharmaceuticals To Sell Entire Stake In Unit Ratnatris Pharmaceuticals Via Shares Swap
Brief: Remus Pharmaceuticals To Make Strategic Investment In Espee Biopharma & Finechem LLC
Brief: Remus Pharmaceuticals Approved In Principle To Incorporate 2 Subsidiaries And 2 Wholly Owned Subsidiaries Outside India